Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis' New Oncology CEO Liz Barrett Charts A Course, But It Will Require Jump-Starting New Brands

Jun 06 2018

• By Jessica Merrill

Basel, Switzerland - 27 August, 2016: sign on the wall of a Novartis building. Novartis International AG is a Swiss pharmaceutical company based in Basel, Switzerland.

Related Content

Lutathera Approval Positions Novartis To Regain NET Share Taken By Ipsen

Jan 29 2018

ASCO 2018: Optimism As Industry Resets And Looks To What Is Next

Jun 04 2018

Novartis Rejiggers Pharma To Favor Oncology

May 18 2016

Novartis Beats CAR-T Competitors To The Pricing Punch With Kymriah Approval

Aug 31 2017

Novartis taps Penn University for cancer immunotherapy

Aug 06 2012

Related Companies

Novartis AG

Pfizer Inc.

Advanced Accelerator Applications SA

Merck & Co., Inc.

Bristol Myers Squibb Company

Eli Lilly and Company

Gilead Sciences, Inc.

Additional Topics

Leadership Launches ImmunoOncology Strategy Commercial Cancer BioPharmaceutical ASCO

More from Leadership

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window